Page 11 - Casos Clínicos de Cardiologia em Intervenção

CASOS CLÍNICOS EM CARDIOLOGIA DE INTERVENÇÃO

Bibliografía | Bibliografia
1. Garrone P, Biondi‑Zoccai G, Salvetti I, Sina N, Sheiban I, Stella PR, et al. Quantitative coronary angiography in the current era: principles and applications.
J Interv Cardiol. 2009; 22(6): 527-536 [DOI: 10.1111/j.1540-8183.2009.00491.x].
2. Cruz Ferreira R, Pereira‑Da‑Silva T, Patrício L, Bezerra H, Costa M. Coronary optical coherence tomography: a practical overview of current clinical appli-
cations. Rev Port Cardiol. 2016; 35(2): 105-112 [DOI: 10.1016/j.repc.2015.09.016].
3. Yabushita H, Bouma BE, Houser SL, Aretz HT, Jang IK, Schlendorfet KH, et al. Characterization of human atherosclerosis by optical coherence tomography.
Circulation. 2002; 106(13): 1.640-1.645 [DOI: 10.1161/01.CIR.0000029927.92825.F6].
4. López JJ, Arain SA, Madder R, Parekh N, Shroff AR, Westerhausen D. Techniques and best practices for optical coherence tomography: a practical manual
for interventional cardiologists. Catheter Cardiovasc Interv. 2014; 84(5): 687-699 [DOI: 10.1002/ccd.25500].
5. Räber L, Mintz GS, Koskinas KC, Johnson TW, Holm NR, Onumaet Y, et al. Clinical use of intracoronary imaging (I): guidance and optimization of coronary
interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. EuroIntervention. 2018; 14(6):
656-677 [DOI: 10.4244/EIJY18M06-01].
6. Francaviglia B, Capranzano P, Gargiulo G, Longo G, Tamburino CI, Ohno Y, et al. Usefulness of 3D OCT to diagnose a noncircumferential open-cell stent
fracture. JACC Cardiovasc Imaging. 2016; 9(2): 210-211 [DOI: 10.1016/j.jcmg.2015.01.011].
7. Zafar H, Ullah I, Dinneen K, Matiullah S, Hanley A, Leahy MJ, et al. Evaluation of hemodynamically severe coronary stenosis as determined by fractional
flow reserve with frequency domain optical coherence tomography measured anatomical parameters. J Cardiol. 2014; 64(1): 19-24 [DOI: 10.1016/j.jjcc.2013.11.009].
8. Reith S, Battermann S, Jaskolka A, Lehmacher W, Hoffmann R, Marx N, et al. Relationship between optical coherence tomography derived intraluminal
and intramural criteria and haemodynamic relevance as determined by fractional flow reserve in intermediate coronary stenoses of patients with type 2
diabetes. Heart. 2013; 99(10): 700-707 [DOI: 10.1136/heartjnl-2013-303616].
9. Shiono Y, Kitabata H, Kubo T, Masuno T, Ohta S, Ozaki Y, et al. Optical coherence tomography-derived anatomical criteria for functionally significant
coronary stenosis assessed by fractional flow reserve. Circ J. 2012; 76(9): 2.218-2.225 [DOI: 10.1253/circj.CJ-12-0195].
10. Yu W, Huang J, Jia D, Chen S, Raffel OC, Ding D, et al. Diagnostic accuracy of intracoronary optical coherence tomography-derived fractional flow reserve
for assessment of coronary stenosis severity. EuroIntervention. 2019; 15(2): 189-197 [DOI: 10.4244/eij-d-19-00182].
11. Gerbaud E, Weisz G, Tanaka A, Kashiwagi M, Shimizu T, Wang L, et al. Multi-laboratory inter-institute reproducibility study of IVOCT and IVUS assessments
using published consensus document definitions. Eur Heart J Cardiovasc Imaging. 2016; 17(7): 756-764 [DOI: 10.1093/ehjci/jev229].
12. Maehara A, Matsumura M, Ali ZA, Mintz GS, Stone GW. IVUS-guided versus OCT-guided coronary stent implantation: a critical appraisal. JACC Cardiovasc
Imaging. 2017; 10(12): 1.487-1.503 [DOI: 10.1016/j.jcmg.2017.09.008].
13. Di Vito L, Yoon JH, Kato K, Yonetsu T, Vergallo R, Costa M, et al.; COICO group (Consortium of Investigators for Coronary OCT). Comprehensive
overview of definitions for optical coherence tomography-based plaque and stent analyses. Coron Artery Dis. 2014; 25(2): 172-185 [DOI: 10.1097/
MCA.0000000000000072].
14. Ali ZA, Maehara A, Généreux P, Shlofmitz RA, Fabbiocchi F, Nazif TM, et al.; ILUMIEN III: OPTIMIZE PCI Investigators. Optical coherence tomography
compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled
trial. Lancet. 2016; 388(10060): 2.618-2.628 [DOI: 10.1016/S0140-6736(16)31922-5].
15. Prati F, Di Vito L, Biondi‑Zoccai G, Occhipinti M, La Manna A, Tamburino C, et al. Angiography alone versus angiography plus optical coherence tomog-
raphy to guide decision-making during percutaneous coronary intervention: the Centro per la Lotta contro l’Infarto-Optimisation of Percutaneous Coronary
Intervention (CLI-OPCI) study. EuroIntervention. 2012; 8(7): 823-829 [DOI: 10.4244/EIJV8I7A125].
16. Meneveau N, Souteyrand G, Motreff P, Caussin C, Amabile N, Ohlmann P, et al. Optical coherence tomography to optimize results of percutaneous
coronary intervention in patients with non-ST-elevation acute coronary syndrome: results of the multicenter, randomized DOCTORS study (Does Optical
Coherence Tomography Optimize Results of Stenting). Circulation. 2016; 134(13): 906-917 [DOI: 10.1161/circulationaha.116.024393].
17. Habara M, Nasu K, Terashima M, Kaneda H, Yokota D, Ko E, et al. Impact of frequency-domain optical coherence tomography guidance for optimal
coronary stent implantation in comparison with intravascular ultrasound guidance. Circ Cardiovasc Interv. 2012; 5(2): 193-201 [DOI: 10.1161/circinterven-
tions.111.965111.193].
18. Kubo T, Shinke T, Okamura T, Hibi K, Nakazawa G, Morino Y, et al.; OPINION Investigators. Optical frequency domain imaging vs. intravascular ultrasound in
percutaneous coronary intervention (OPINION trial): one-year angiographic and clinical results. Eur Heart J. 2017; 38(42): 3.139-3.147 [DOI: 10.1093/eurheartj/ehx351].
19. Marenzi G, Lauri G, Assanelli E, Campodonico J, De Metrio M, Marana I, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty
for acute myocardial infarction. J Am Coll Cardiol. 2004; 44(9): 1.780-1.785 [DOI: 10.1016/j.jacc.2004.07.043].
20. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Inter
Suppl 2012;2(1):1-38.
21. Barrett BJ, Parfrey PS. Preventing nephropathy induced by contrast medium. N Engl J Med. 2006; 354(17): 379-386 [DOI: 10.1056/NEJMc060405].
22. Barrett J, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality lodinated contrast media. Radiology. 1993; 188: 171-178.
23. Aspelin P, Aubry P, Fransson S‑G, Strasser R, Willenbrock R, Berg KJ. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med.
2006; 348: 491-499 [DOI: 10.1056/NEJMoa1109071].
24. Heinrich MC, Häberle L, Müller V, Bautz W, Uder M. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media:
meta-analysis of randomized controlled trials. Radiology. 2009; 250(1): 68-86 [DOI: 10.1148/radiol.2501080833].
25. Van Der Sijde JN, Karanasos A, Van Ditzhuijzen NS, Okamura T, van Geuns RJ, Valgimigli M, et al. Safety of optical coherence tomography in daily
practice: a comparison with intravascular ultrasound. Eur Heart J Cardiovasc Imaging. 2017; 18(4): 467-474 [DOI: 10.1093/ehjci/jew037].

11